Top compounds associated with response to DTD2


Feature Type Standardized
Nominal ANOVA
mRNA fulvestrant CTRPv2 pan-cancer AAC 0.068 0.4
mRNA BMS-754807 CTRPv2 pan-cancer AAC -0.028 0.4
mRNA AZD1480 CTRPv2 pan-cancer AAC -0.044 0.4
mRNA AZD7762 CTRPv2 pan-cancer AAC -0.027 0.4
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.028 0.4
mRNA WAY-362450 CTRPv2 pan-cancer AAC -0.031 0.4
mRNA BRD-K90370028 CTRPv2 pan-cancer AAC -0.045 0.4
mRNA 3-Cl-AHPC CTRPv2 pan-cancer AAC -0.028 0.4
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.028 0.4
mRNA AZD8055 CTRPv2 pan-cancer AAC 0.029 0.4
Download CSV